Company Overview of Inhibitex, Inc.
Key Executives for Inhibitex, Inc.
|Russell H. Plumb M.B.A.||19 Relationships||Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer||57|
|Demetrios Kydonieus||7 Relationships||President and Director||--|
|Joseph M. Patti M.S.P.H., Ph.D.||9 Relationships||Founder, Chief Scientific Officer, Senior Vice President of Research & Development and Assistant Secretary||52|
|Geoffrey W. Henson Ph.D.||No Relationships||Senior Vice President of Drug Development||68|
|Seth Hetherington M.D.||No Relationships||Chief Medical Officer and Vice President of Clinical Development||64|
Inhibitex, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Demetrios Kydonieus||7 Relationships||Inhibitex, Inc.||--|
|Jeffrey Galik||18 Relationships||ZymoGenetics, Inc.||--|
|Erik De Clercq M.D., Ph.D.||7 Relationships||Inhibitex, Inc.||--|
|Robert T. Schooley M.D.||95 Relationships||Gilead Sciences Inc.||--|
|Charles Flexner M.D.||7 Relationships||Inhibitex, Inc.||--|
Inhibitex, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Advisory Board M.D., Ph.D.||Erik De Clercq||7 Relationships||5 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$364.0K|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.